{{#EntryImageUrl}}
![Class of Migraine Drug, CGRP Inhibitors, Has Added Benefit: Reduced Glaucoma Risk]()
{{/EntryImageUrl}}
Class of Migraine Drug, CGRP Inhibitors, Has Added Benefit: Reduced Glaucoma Risk
Published on May 7, 2026 at 03:35PM by Drugs.com - Daily MedNews
THURSDAY, May 7, 2026 — A class of drugs taken to prevent migraines might help people avoid glaucoma as well, a new study says.
People taking CGRP (calcitonin gene-related peptide) inhibitors had a 25% lower risk of developing glaucoma...
Read the original article here: https://www.drugs.com/news/class-migraine-cgrp-inhibitors-has-added-benefit-reduced-glaucoma-risk-129934.html